+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Risk factors and outcome of pulmonary complications after autologous hematopoietic stem cell transplant



Risk factors and outcome of pulmonary complications after autologous hematopoietic stem cell transplant



Chest 141(2): 442-450



Most reports addressing pulmonary complications (PCs) in hematopoietic stem cell transplant (HSCT) recipients have focused on allogeneics. This study describes the PCs, their risk factors, and the impact on mortality in autologous recipients. We reviewed the medical records of 1,243 adult autologous HSCT recipients. We collected pretransplant and posttransplant data and data on PC after transplant and long-term mortality. Four hundred eighty-seven PC developed in 343 patients (27.6%): 173 infectious (13.9%), 127 noninfectious (10.2%), and 43 both infectious and noninfectious (3.5%). Bacterial, fungal, and viral pneumonias were the most common infectious complications. The main noninfectious complications were acute pulmonary edema (APE) (59 [4.7%]), diffuse alveolar hemorrhage (DAH) (26 [2.1%]), peri-engraftment respiratory distress syndrome (PERDS) (31 [2.5%]), and idiopathic pneumonia syndrome (IPS) (12 [1.0%]). Independent factors associated with PC included diffusing capacity of lung for carbon monoxide and indications for transplant. Factors associated with mortality included sex, history of pulmonary disease, disease status at the time of transplant, FVC, Karnofsky score, and underlying diagnosis. A Cox proportional hazards regression model with separate time-dependent predictors for the first 1 month, 1 to 2 months, 2 to 6 months, and 6 or more months showed an association with mortality at hazard ratios (HRs) of 32.39, 10.13, 4.29, and 0.98, respectively, compared with persons without PC. More than 25% of autologous HSCT recipients develop PCs within 1 year of transplant. Most of the complications are infections. The most common noninfectious complications are APE, DAH, PERDS, and IPS. PCs increase the risk of death, with HR as high as 32.

(PDF emailed within 0-6 h: $19.90)

Accession: 055579238

Download citation: RISBibTeXText

PMID: 21778261

DOI: 10.1378/chest.10-2889


Related references

Outcome of autologous hematopoietic stem cell transplant for patients with non-Hodgkins lymphoma that fail to mobilize autologous peripheral blood stem cells. Blood 96(11 Part 1): 795a, November 16, 2000

Impact of pre-transplant risk factors on post-transplant outcome of patients with acute myeloid leukemia in remission following haploidentical hematopoietic stem cell transplantation. 2012

Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients. Annals of Hematology 93(2): 299-307, 2014

Severe sepsis in autologous stem cell transplant recipients: microbiological aetiology, risk factors and outcome. Scandinavian Journal of Infectious Diseases 41(1): 14-20, 2008

Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplant. Leukemia & Lymphoma 55(8): 1922-1924, 2015

Norovirus infection in pediatric hematopoietic stem cell transplant recipients incidence, risk factors and outcome. 2012

Outcome of Autologous Hematopoietic Stem Cell Transplant Outcome for Non-Hodgkin Lymphoma in Patients Age 60 Years or Older. Blood 100(11): Abstract No 678, November 16, 2002

Risk factors analysis of infections complications during severe neutropenia after high dose therapy and autologous hematopoietic stem cell transplantation. Acta Haematologica Polonica 37(3): 387-398, 2006

Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation. European Journal of Haematology 87(2): 138-147, 2011

Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome. Infection 35(6): 421-427, 2007

Veno-occlusive disease of the liver after autologous and allogeneic hematopoietic stem cell transplantation in children Incidence, risk factors and outcome. Blood 94(10 SUPPL 1 PART 1): 709a, Nov 15, 1999

Outcome and risk factors for late-onset complications twenty-four months beyond allogeneic hematopoietic stem cell transplantation. 2011

Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 98(3): 573-578, 2001

Risk factors for invasive pulmonary fungal infection in patients with hematological malignancies not receiving hematopoietic stem cell transplant. Neoplasma 59(6): 669-675, 2013

The incidence and risk factors of late-onset non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation.. Zhonghua Xue Ye Xue Za Zhi 31(4): 249-252, 2016